Position in CYCN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,201,963
+$2,194,616 QoQ
Shares Held
649,547
+13603.5% QoQ
Ownership
13.9%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2
of 21 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYCN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FMR LLC holds $61,424,667,384 across 370 Biotechnology names. CYCN ranks #197 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
5,231,452 | $4,853,584,218 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
15,023,962 | $4,522,663,276 | |
| 3 | MRNA |
Moderna, Inc.
|
51,859,891 | $3,631,748,165 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
81,020,390 | $2,867,311,601 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
12,200,422 | $2,284,895,029 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,631,956 | $1,953,067,789 | |
| 7 | INSM |
INSMED Inc
|
16,143,583 | $1,721,228,815 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
4,418,197 | $1,642,111,277 |
All Filings in CYCN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,201,963 | 649,547 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $7,347 | 4,740 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $6,019 | 4,740 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $10,915 | 4,746 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $13,793 | 4,740 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $12,350 | 4,940 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $15,262 | 4,740 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $408,277 | 157,636 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $371,263 | 161,419 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $519,445 | 162,327 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $545,543 | 162,849 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $562,756 | 164,549 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $679,589 | 164,949 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,471,416 | 3,390,363 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $2,244,149 | 3,420,963 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,935,921 | 3,413,863 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $1,393,208 | 2,537,723 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,902,659 | 2,615,010 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $4,501,944 | 2,617,410 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $8,131,231 | 2,648,610 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $10,431,762 | 2,674,811 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $7,606,407 | 2,726,311 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $8,322,315 | 2,719,711 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $16,639,202 | 2,736,711 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $16,217,731 | 2,744,117 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $7,271,943 | 2,744,130 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||